Donor-Specific Antibodies Accelerate Arteriosclerosis after Kidney Transplantation
Authors:
- Gary S. HillGHGary S. Hill
- Dominique NochyDNDominique Nochy
- Patrick BrunevalPBPatrick Bruneval
- J. P. Duong van HuyenJHJ. P. Duong van Huyen
- Denis GlotzDGDenis Glotz
- Caroline SuberbielleCSCaroline Suberbielle
- Julien ZuberJZJulien Zuber
- Dany AnglicheauDADany Anglicheau
- Jean-Philippe EmpanaJEJean-Philippe Empana
- Christophe LegendreCLChristophe Legendre
- Alexandre LoupyALAlexandre Loupy
- 1 May 2011
- journal article
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 22 (5) , 975-983
Abstract
In biopsies of renal allografts, arteriosclerosis is often more severe than expected based on the age of the donor, even without a history of rejection vasculitis. To determine whether preformed donor-specific antibodies (DSAs) may contribute to the severity of arteriosclerosis, we examined protocol biopsies from patients with (n = 40) or without (n = 59) DSA after excluding those with any evidence of vasculitis. Among DSA-positive patients, arteriosclerosis significantly progressed between month 3 and month 12 after transplant (mean Banff cv score 0.65 ± 0.11 to 1.12 ± 0.10, P = 0.014); in contrast, among DSA-negative patients, we did not detect a statistically significant progression during the same timeframe (mean Banff cv score 0.65 ± 0.11 to 0.81 ± 0.10, P = not significant). Available biopsies at later time points supported a rate of progression of arteriosclerosis in DSA-negative patients that was approximately one third that in DSA-positive patients. Accelerated arteriosclerosis was significantly associated with peritubular capillary leukocytic infiltration, glomerulitis, subclinical antibody-mediated rejection, and interstitial inflammation. In conclusion, these data support the hypothesis that donor-specific antibodies dramatically accelerate post-transplant progression of arteriosclerosis.Keywords
This publication has 22 references indexed in Scilit:
- Combined Posttransplant Prophylactic IVIg/Anti-CD 20/Plasmapheresis in Kidney Recipients With Preformed Donor-Specific Antibodies: A Pilot StudyTransplantation, 2010
- Clinicopathological analysis of acute vascular rejection cases after renal transplantationClinical Transplantation, 2010
- Accelerated arteriosclerosis: a form of transplant arteriopathyCurrent Opinion in Organ Transplantation, 2010
- Anti-HLA I antibodies induce VEGF production by endothelial cells, which increases proliferation and paracellular permeabilityThe International Journal of Biochemistry & Cell Biology, 2009
- Relevance of MICA and other non-HLA antibodies in clinical transplantationCurrent Opinion in Immunology, 2008
- Clinical Relevance of Preformed HLA Donor-Specific Antibodies in Kidney TransplantationAmerican Journal of Transplantation, 2008
- Kidney Transplantation: Mechanisms of Rejection and AcceptanceAnnual Review of Pathology: Mechanisms of Disease, 2008
- The Emerging Issue of MICA Antibodies: Antibodies to MICA and Other Antigens of Endothelial Cells2008
- Subclinical Acute Antibody-Mediated Rejection in Positive Crossmatch Renal AllograftsAmerican Journal of Transplantation, 2007
- The Banff 97 working classification of renal allograft pathologyKidney International, 1999